Ridgeback Capital Investments L.P. filings

This page lists the SEC filings reported by Ridgeback Capital Investments L.P..

SEC filings by Ridgeback Capital Investments L.P. (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2008-03-20Ridgeback Capital Investments L.P.INCYTE CORP5,102,8996.0%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.Chelsea Therapeutics International, Ltd.2,927,9429.8%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.BIODELIVERY SCIENCES INTERNATIONAL INC341,4421.8%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.ISOLAGEN INC2,754,9006.6%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.Adams Respiratory Therapeutics, Inc.-0.0%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.MOMENTA PHARMACEUTICALS INC1,768,5924.8%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.AVANIR PHARMACEUTICALS-0.0%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.Biodel Inc1,848,0009.2%EDGAR
SC 13G/A2008-02-14Ridgeback Capital Investments L.P.ACADIA PHARMACEUTICALS INC-0.0%EDGAR
SC 13G2008-02-11Ridgeback Capital Investments L.P.SAVIENT PHARMACEUTICALS INC2,925,0005.5%EDGAR
SC 13G2008-01-18Ridgeback Capital Investments L.P.ZYMOGENETICS INC5,195,0007.6%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.